Search research articles
Contact Us
Filters
Showing results (421-430 of 472) with videos related to
Page
of 48
Sort By:
Cancer Biology & Therapy
|
December 23, 2003
An essential role of Th1 responses and interferon gamma in infection-mediated suppression of neoplastic growth
Erinn B Rankin, Duonan Yu, Jiu Jiang, et al.
Veterinary and Comparative Oncology
|
August 21, 2009
Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence
K U Sorenmo, V M Kristiansen, M A Cofone, et al.
British Journal of Cancer
|
April 3, 1999
Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer
S Hohaus, L Funk, S Martin, et al.
Leukemia
|
February 19, 2014
Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma
M Merz, T Hielscher, B Wagner, et al.
Oncogenesis
|
May 16, 2017
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation
J Xu, N Pfarr, V Endris, et al.
Plos Pathogens
|
July 23, 2013
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis
Fernanda O Novais, Lucas P Carvalho, Joel W Graff, et al.
Leukemia
|
October 8, 2004
Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy
M C Minnema, I Breitkreutz, J J A Auwerda, et al.
Leukemia
|
April 26, 2017
Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes
P Hari, M-V Mateos, R Abonour, et al.
Leukemia
|
February 11, 2017
RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma
E Viziteu, B Klein, J Basbous, et al.
BMC Cancer
|
April 14, 2005
Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759]
H P Knaebel, A Märten, J Schmidt, et al.
Page
of 48
Search research articles
Search
Showing results (421-430 of 472) with videos related to
Sort By:
Page
of 48
Cancer Biology & Therapy
|
December 23, 2003
An essential role of Th1 responses and interferon gamma in infection-mediated suppression of neoplastic growth
Erinn B Rankin, Duonan Yu, Jiu Jiang, et al.
Veterinary and Comparative Oncology
|
August 21, 2009
Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence
K U Sorenmo, V M Kristiansen, M A Cofone, et al.
British Journal of Cancer
|
April 3, 1999
Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer
S Hohaus, L Funk, S Martin, et al.
Leukemia
|
February 19, 2014
Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma
M Merz, T Hielscher, B Wagner, et al.
Oncogenesis
|
May 16, 2017
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation
J Xu, N Pfarr, V Endris, et al.
Plos Pathogens
|
July 23, 2013
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis
Fernanda O Novais, Lucas P Carvalho, Joel W Graff, et al.
Leukemia
|
October 8, 2004
Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy
M C Minnema, I Breitkreutz, J J A Auwerda, et al.
Leukemia
|
April 26, 2017
Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes
P Hari, M-V Mateos, R Abonour, et al.
Leukemia
|
February 11, 2017
RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma
E Viziteu, B Klein, J Basbous, et al.
BMC Cancer
|
April 14, 2005
Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759]
H P Knaebel, A Märten, J Schmidt, et al.
Page
of 48